Refractory Epilepsy Screening Tool for Lennox–Gastaut Syndrome (REST-LGS)
Provides diagnostic criteria for Lennox-Gastaut Syndrome (LGS).
Advice
- This tool does not provide a definitive diagnosis of LGS; always interpret the score in the context of clinical judgment, patient history, and a full neurologic work‑up, with specialist input as needed.
- LGS is a clinical diagnosis with diverse etiologies; the following investigations may aid in the evaluation:
- EEG: To document characteristic interictal slow spike‑and‑wave or paroxysmal fast activity.
- Brain MRI: To identify structural brain abnormalities.
- Genetic testing, including epilepsy gene panel and chromosomal microarray: To detect pathogenic variants associated with LGS.
- Metabolic testing: Consider when imaging and genetic testing are unrevealing to evaluate for neurometabolic disorders.
- Referral to a comprehensive epilepsy center: For specialist evaluation and multidisciplinary management.